• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌患者中白细胞介素-10和转化生长因子-β水平以及髓样和淋巴样树突状细胞的评估。

Evaluation of IL-10 and TGF-β levels and myeloid and lymphoid dendritic cells in ovarian cancer patients.

作者信息

Wertel Iwona, Polak Grzegorz, Tarkowski Rafał, Kotarska Maria

机构信息

Department of Oncological Gynaecology and Gynaecology, Medical University, Lublin, Poland.

出版信息

Ginekol Pol. 2011 Jun;82(6):414-20.

PMID:21853929
Abstract

AIM

The aim of the study was to evaluate IL-10 and TGF-beta levels in the peritoneal fluid (PF) and plasma of patients with ovarian cancer (n=104), serous cyst (n=32) or normal controls (n=20). IL-10 and TGF-beta levels were correlated to myeloid (M) and lymphoid (L) dendritic cells (DC).

MATERIAL AND METHODS

IL- 10 and TGF-beta concentrations were evaluated using the enzyme linked immunosorbent assay (ELISA). The percentage of DC in mononuclear cells was quantified by using flow cytometry.

RESULTS

The PF and plasma IL-10 concentrations were significantly higher in epithelial ovarian cancer (EOC) patients when compared to the women with serous cyst (the reference group). Plasma levels of IL-10 were elevated in EOC patients in comparison with the reference and control groups. There were significant differences in the PF and plasma IL-10 levels with respect to tumor stage, grade and histology Significant negative correlations were found between the plasma IL-10 levels, MDC and LDC in the peripheral blood. TGF-beta levels were detected in PF of all EOC patients and were significantly lower when compared with plasma. Plasma levels of TGF-beta were elevated in EOC patients compared with the control group. No significant differences in the PF and plasma TGF-beta levels were noted between EOC patients and the reference group. The authors did not find a correlation between the plasma and PF TGF-beta levels and the percentage of MDC and LDC.

CONCLUSIONS

IL-10 production in EOC patients depends on the tumor stage, grade and histological type of the tumor cells. IL-10 may have impact on the percentage of dendritic cells in EOC patients.

摘要

目的

本研究旨在评估卵巢癌患者(n = 104)、浆液性囊肿患者(n = 32)或正常对照者(n = 20)的腹腔液(PF)和血浆中白细胞介素-10(IL-10)及转化生长因子-β(TGF-β)水平。IL-10和TGF-β水平与髓样(M)和淋巴样(L)树突状细胞(DC)相关。

材料与方法

采用酶联免疫吸附测定(ELISA)评估IL-10和TGF-β浓度。通过流式细胞术定量单核细胞中DC的百分比。

结果

与浆液性囊肿患者(参照组)相比,上皮性卵巢癌(EOC)患者的PF和血浆IL-10浓度显著更高。与参照组和对照组相比,EOC患者的血浆IL-10水平升高。PF和血浆IL-10水平在肿瘤分期、分级和组织学方面存在显著差异。外周血中血浆IL-10水平与MDC和LDC之间存在显著负相关。所有EOC患者的PF中均检测到TGF-β水平,与血浆相比显著更低。与对照组相比,EOC患者的血浆TGF-β水平升高。EOC患者与参照组之间的PF和血浆TGF-β水平未发现显著差异。作者未发现血浆和PF中TGF-β水平与MDC和LDC百分比之间存在相关性。

结论

EOC患者中IL-10的产生取决于肿瘤细胞的肿瘤分期、分级和组织学类型。IL-10可能对EOC患者树突状细胞的百分比有影响。

相似文献

1
Evaluation of IL-10 and TGF-β levels and myeloid and lymphoid dendritic cells in ovarian cancer patients.卵巢癌患者中白细胞介素-10和转化生长因子-β水平以及髓样和淋巴样树突状细胞的评估。
Ginekol Pol. 2011 Jun;82(6):414-20.
2
SDF-1alpha/CXCL12 and dendritic cells in ovarian cancer microenvironment.卵巢癌微环境中的基质细胞衍生因子-1α/趋化因子配体12与树突状细胞
Ginekol Pol. 2011 Jun;82(6):421-5.
3
Relationship between RANTES and dendritic cells in ovarian cancer patients.卵巢癌患者中RANTES与树突状细胞的关系。
Front Biosci (Elite Ed). 2011 Jan 1;3(1):227-32. doi: 10.2741/e237.
4
Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer.晚期卵巢癌患者血浆和腹水中白细胞介素-10及转化生长因子-β水平升高。
BJOG. 2001 Aug;108(8):804-8. doi: 10.1111/j.1471-0528.2001.00206.x.
5
Dendritic cell subsets in the peritoneal fluid and peripheral blood of women suffering from ovarian cancer.卵巢癌女性腹膜液和外周血中的树突状细胞亚群
Cytometry B Clin Cytom. 2008 Jul;74(4):251-8. doi: 10.1002/cyto.b.20410.
6
The expression of interleukin-10 in patients with primary ovarian epithelial carcinoma and in ovarian carcinoma cell lines.原发性卵巢上皮癌患者及卵巢癌细胞系中白细胞介素-10的表达。
J Int Med Res. 2007 May-Jun;35(3):290-300. doi: 10.1177/147323000703500302.
7
Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients.卵巢癌患者体内巨噬细胞源性趋化因子CCL22与调节性T细胞
Tumour Biol. 2015 Jun;36(6):4811-7. doi: 10.1007/s13277-015-3133-8. Epub 2015 Feb 3.
8
Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers.腹水中的炎症调节因子作为浆液性上皮性卵巢癌耐药性和无进展生存期的预测生物标志物。
BMC Cancer. 2015 Jul 1;15:492. doi: 10.1186/s12885-015-1511-7.
9
Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer.初次手术时腹水的细胞因子分析表明,肿瘤坏死因子-α和白细胞介素-6之间的相互作用可预测上皮性卵巢癌无进展生存期缩短。
Gynecol Oncol. 2015 Aug;138(2):352-7. doi: 10.1016/j.ygyno.2015.05.009. Epub 2015 May 20.
10
Interleukin-7 and suppression of local peritoneal immunity in ovarian carcinoma.白细胞介素-7与卵巢癌局部腹膜免疫抑制
Int J Gynaecol Obstet. 2004 May;85(2):151-8. doi: 10.1016/j.ijgo.2003.08.015.

引用本文的文献

1
IL-10 Signaling in the Tumor Microenvironment of Ovarian Cancer.卵巢癌肿瘤微环境中的 IL-10 信号传导。
Adv Exp Med Biol. 2021;1290:51-65. doi: 10.1007/978-3-030-55617-4_3.
2
Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer.上皮性卵巢癌中循环和浸润髓系来源抑制细胞(MDSC)亚群的临床相关性和免疫抑制模式。
Front Immunol. 2019 Apr 3;10:691. doi: 10.3389/fimmu.2019.00691. eCollection 2019.
3
Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells.
卵巢癌 I 型和 II 型微环境对单核细胞来源树突状细胞表型和功能的影响。
Clin Transl Oncol. 2017 Dec;19(12):1489-1497. doi: 10.1007/s12094-017-1686-2. Epub 2017 Jun 6.
4
Plasma immune analytes in patients with epithelial ovarian cancer.上皮性卵巢癌患者的血浆免疫分析物
Cytokine. 2015 May;73(1):108-13. doi: 10.1016/j.cyto.2015.01.035. Epub 2015 Mar 3.